1
/
of
0
FDA Drug Approval, N086513, SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
FDA Drug Approval, N086513, SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 086513
Company: MYLAN
Drug Name: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Active Ingredients: HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
Strength: 25MG;25MG
Dosage Form/Route: TABLET;ORAL
Action Date: 08/03/1979
Marketing Status: Prescription
Submission Classification:
Company: MYLAN
Drug Name: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Active Ingredients: HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
Strength: 25MG;25MG
Dosage Form/Route: TABLET;ORAL
Action Date: 08/03/1979
Marketing Status: Prescription
Submission Classification:
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details